Yale Bulletin and Calendar

February 29, 2008|Volume 36, Number 20

Study offers insight into
possible cause of lymphoma

The immune system’s powerful cellular mutation and repair processes appear to offer important clues as to how lymphatic cancer develops, Yale School of Medicine researchers reported Feb. 13 in Nature.

“The implications of these findings are considerable,” says David Schatz, a Howard Hughes Medical Institute investigator, professor of immunobiology at Yale and senior author of the study. “It now seems likely that anything that compromises the function of these DNA repair processes could lead to widespread mutations and an increased risk of cancer.”

The lymph system is made up of infection-fighting B cells. Schatz and his colleagues examined the somatic hypermutation (SHM) process, which introduces random mutations in B cells’ antibody genes to make them more effective in fighting infection.

SHM occurs in two steps: First, a mutation initiator, or activation-induced deaminase (AID), causes genetic mutations. Second, DNA repair enzymes spot the changes and begin making “sloppy” repairs, which lead to yet more mutations. The two steps combined, Schatz says, present a major risk to genomic stability.

Interestingly, these same repair enzymes recognize mutations in many other types of genes in the B cells, but they fix those genes in a precise, or “high-fidelity,” manner.

Up until now it was thought the risk to genomic stability was avoided for the most part because the first step of the SHM process only happened in antibody genes. But this study showed that AID acts on many other genes in B cells, including genes linked to lymphatic cancer and other malignancies.

“And then we had another surprise,” Schatz says.

“Most of these non-antibody genes do not accumulate mutations because the repair, for whatever reason, is precise, not sloppy.”

What this means, Schatz says, is that researchers studying lymphatic cancer must understand both the first and the second step — the original mutations and then the repair process.

“If the precise, or high-fidelity, repair processes break down, this would unleash the full mutagenic potential of the initial mutation, resulting in changes in many important genes,” Schatz says. “We hypothesize that exactly this sort of breakdown of the repair processes occurs in the early stages of the development of B cell tumors.”

— By Jacqueline Weaver

T H I SW E E K ' SS T O R I E S

Yale-engineered virus can attack brain tumors

Trustees set next steps in residential college expansion

Going back to the ‘basics’ of medicine on the wards of Uganda

New center promotes the study of Hellenic culture and civilization

Study to examine Internet-based programs for diabetic children

Study offers insight into possible cause of lymphoma

Lorimer lauded for contributions to corporate boards

Yale chemist honored for contributions to teaching . . .

Show documents people and fauna of the ‘New World’

‘Chronicler of American life’ is next Maynard Mack lecturer

Contemporary images of the Virgin Mary are featured in . . .

Symposium will explore human rights issues related to . . .

Police Academy for citizens to be held this spring

Arabic music past and present is explored in new exhibition

Chinese ‘Year of the Rat’ celebrated at Yale

Hundreds of schoolchildren will gather in Yale ‘castle’ . . .

Yale Books in Brief

Campus Notes